2025-05-02 20:38:59
Latest Post
Railtel Corporation of India Ltd Q4 FY2025 net profit surges to Rs. 113.45 crores
Jaiprakash Power Ventures Ltd Q4 FY25 consolidated net profit at Rs. 155.67 crores
Nuvoco Vistas Corporation Ltd Q4 FY2025 consolidated PAT soars to Rs. 165.54 crores
5paisa Capital Ltd consolidated Q4FY25 profit slides QoQ to Rs. 10.06 crores
Home First Finance Company India Ltd Q4 FY2025 PAT up at Rs. 104.69 crores
Stock Report
Emmessar Biotech and Nutrition Ltd Q4FY22 PAT at Rs. 3.47 lakhs
Posted On : 2022-05-21 13:37:01( TIMEZONE : IST )
EMMESSAR BIOTECH & NUTRITION LTD. has reported Standalone financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 0.8524 crores during the period ended March 31, 2022 as compared to Rs. 0.5670 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 0.0347 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 0.1692 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 0.05 for the period ended March 31, 2022 as compared to Rs. 0.34 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 0.8524 crs | ₹0.5670 crs |  50.34% |
| Net Profit | ₹0.0347 crs | ₹0.1692 crs |  -79.49% |
| EPS | ₹0.05 | ₹0.34 | -85.29% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 0.8524 crores during the period ended March 31, 2022 as compared to Rs.4.8834 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.0.0347 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.0.5157 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.0.05 for the period ended March 31, 2022 as compared to Rs.1.01 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 0.8524 crs | ₹4.8834 crs | -82.54% |
| Net Profit | ₹0.0347 crs | ₹0.5157 crs | -93.27% |
| EPS | ₹0.05 | ₹1.01 | -95.05% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.2.2837 crores during the Financial Year ended March 31, 2022 as compared to Rs.8.4564 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.0.4754 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.1.4497 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.0.94 for the Financial Year ended March 31, 2022 as compared to Rs.2.88 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹2.2837 crs | ₹8.4564 crs | -72.99% |
| Net Profit | ₹0.4754 crs | ₹1.4497 crs | -67.21% |
| EPS | ₹0.94 | ₹2.88 | -67.36% |
Shares of EMMESSAR BIOTECH & NUTRITION LTD. was last trading in BSE at Rs. 28.55 as compared to the previous close of Rs. 27.20. The total number of shares traded during the day was 2869 in over 29 trades.
The stock hit an intraday high of Rs. 28.55 and intraday low of 26.35. The net turnover during the day was Rs. 81452.00.
